BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36531705)

  • 1. CHA
    Pang H; Zhu X; Cheang I; Zhang H; Zhou Y; Liao S; Li X
    Front Cardiovasc Med; 2022; 9():925932. PubMed ID: 36531705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA
    Luo J; Dai L; Li J; Zhao J; Li Z; Qin X; Li H; Liu B; Wei Y
    Clin Interv Aging; 2018; 13():1099-1109. PubMed ID: 29922048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the CHA
    Chua SK; Huang PS; Chen JJ; Chiu FC; Hwang JJ; Tsai CT
    Hellenic J Cardiol; 2023 Aug; ():. PubMed ID: 37633490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
    Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
    Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term Risk Stratification of Patients with a Myocardial Infarction and Atrial Fibrillation: Beyond GRACE and CHADS.
    Barra S; Providência R; Paiva L; Almeida I; Caetano F; Dinis P; Leitão Marques A
    J Atr Fibrillation; 2013 Dec; 6(4):897. PubMed ID: 28496907
    [No Abstract]   [Full Text] [Related]  

  • 7. [The predictive value of the CHA
    Qing P; Yang YM; Hu LT; Yu W; Xu LL; Wang N; Suo N
    Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):177-184. PubMed ID: 35090253
    [No Abstract]   [Full Text] [Related]  

  • 8. The Value of the CHADS
    Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction.
    Fu Y; Pan Y; Gao Y; Yang X; Chen M
    BMC Cardiovasc Disord; 2021 Apr; 21(1):175. PubMed ID: 33849448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of semi-quantitative CT-based score integrated with cardiovascular risk factors during the first peak of the COVID-19 pandemic: A new score to predict poor outcome.
    Pence MC; Avdan Aslan A; Tunccan OG; Erbas G
    Eur J Radiol; 2022 May; 150():110238. PubMed ID: 35278978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHADS
    Koeda Y; Komatsu T; Matsuura Y; Morioka H; Uchimura Y; Taguchi Y; Tanaka K; Kawakami J; Nakamura M; Takahashi S; Takahashi Y; Naganuma Y; Endo H; Ito T; Morino Y; Nakamura M
    J Arrhythm; 2017 Oct; 33(5):488-493. PubMed ID: 29021855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19.
    Abacioglu OO; Yildirim A
    Rev Assoc Med Bras (1992); 2021 Mar; 67(3):443-448. PubMed ID: 34468612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation and comparison of CHA
    Zheng N; Zhang J
    J Interv Card Electrophysiol; 2022 Nov; 65(2):535-542. PubMed ID: 35831771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHA
    Węgiel M; Rakowski T; Dziewierz A; Wojtasik-Bakalarz J; Sorysz D; Bartuś S; Surdacki A; Dudek D
    Postepy Kardiol Interwencyjnej; 2018; 14(4):391-398. PubMed ID: 30603029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the predictive ability of emergency CHADS
    Huang X; Lv H; Liu Z; Liu Y; Yang X
    J Thorac Dis; 2022 Jul; 14(7):2611-2620. PubMed ID: 35928606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of CHADS
    Pang H; Han B; Fu Q; Zong Z
    Sci Rep; 2017 Jul; 7(1):4730. PubMed ID: 28680116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.